Longitude Capital
VC
INVESTOR TYPE
Active
STATUS
18
PROFESSIONALS
87
INVESTMENTS
34
PORTFOLIO
39
EXITS
Description
Longitude Capital is a venture capital investment firm that invests in the biotechnology and medical technology sectors. The firm specializes in seed, early stage, later stage, spin-outs, recapitalization, PIPE and structured transactions. It was founded in 2006 and is based in Menlo Park, California with an additional office in Greenwich, Connecticut.
Website
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Year Founded
2006
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- 2740 Sand Hill Road
- Suite 200
- Menlo Park, CA 94025
- United States
+1 (650) 000-0000
Longitude Capital Investments (87)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Inflazome | 19-Nov-2018 | Early Stage VC | 0000 | Drug Discovery | Generating Revenue | 00000 000000 00.0 |
| 00000 | 25-Oct-2018 | 00000 00000 | 0000 | Drug Discovery | Startup | 0000000 00000000 00 |
| 0000000 | 17-Oct-2018 | 00000 00000 | 000.00 | Drug Discovery | Startup | 0000000 0000000 |
| 00000000000 | 30-Aug-2018 | 00000 00000 | 0000 | Elder and Disabled Care | Generating Revenue | 0000000 00000000 00 |
| 00000 000000000000 | 29-Aug-2018 | 00000 00000 | 000.00 | Biotechnology | Clinical Trials - Phase 2 | 0000 0000000000 00 |
| 00000000 000000000 | 16-Jul-2018 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | 00000 000000 00.0 |
| 000000000 00000000 | 22-May-2018 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | |
| 00000000 | 19-May-2018 | 00000 00000 | 0000 | Drug Discovery | Pre-Clinical Trials | 0000000 0000000 |
| Neurana Pharmaceuticals | 03-May-2018 | Early Stage VC | 0000 | Drug Discovery | Clinical Trials - General | 0000 0000000000 00 |
| Rapid Micro Biosystems | 02-May-2018 | Later Stage VC | 0000 | Other Devices and Supplies | Generating Revenue | 00000 000000 00.0 |
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Longitude Capital’s full profile, request a free trial.
Longitude Capital Exits (38)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Axonics Modulation Technologies | 31-Oct-2018 | IPO | 00000 | Completed |
|
| 0000000000 0000000 | 06-Aug-2018 | 0000000000 | Completed |
|
|
| 0000000 | 24-Jul-2018 | 000000000000000000 | 00000 | Completed |
|
| 0000000 | 27-Jun-2018 | 000 | 00000 | Completed |
|
| 0000000 | 21-Jun-2018 | 000 | 00000 | Completed |
|
| 000000000 00000000 | 13-Apr-2018 | 000000000 00000000 | Completed |
|
|
| 00000000 000000 | 13-Feb-2018 | 000000000000000000 | 00000 | Completed |
|
| 00000000 000000000 | 25-Sep-2017 | 000000000000000000 | 00000 | Completed |
|
| Akebia Therapeutics | 14-Aug-2017 | Public Investment 2nd Offering | Completed |
|
|
| Kala Pharmaceuticals | 20-Jul-2017 | IPO | 0000 | Completed |
|
Longitude Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is reserved for PitchBook Platform accredited users. To explore Longitude Capital‘s full profile, request access.
Request full access to PitchBookLongitude Capital Team (34)
14 Former Team Members
You’re viewing 5 of 34 team members. Get the full list »Longitude Capital Co-Investors (131)
| Name | With | Exits | Lead Partner |
|---|---|---|---|
| OrbiMed | 7 | 0 | 0 |
| RA Capital Management | 0 | 0 | 0 |
| Adage Capital Management | 0 | 0 | 0 |
| Fountain Healthcare Partners | 0 | 0 | 0 |
| Frazier Healthcare Partners | 0 | 0 | 0 |